Rod Raynovich's  Instablog

Rod Raynovich
Send Message
Rod Raynovich is an entrepreneur and executive with a focus on life science companies and medical technology trends.He has over 30 years executive experience including Abbott and JNJ and has been involved three successful start-ups. He has a B.S, from Penn State University and an MBA from... More
My company:
Raygent Capital
My blog:
  • Targeted Therapy And Diagnostic Biomarker Studies And Services 3/3/13 Update GHDX 0 comments
    May 3, 2013 10:19 AM | about stocks: GHDX

    Genomic Health Up 5% on Higher Q1 Revenues

    An article in the New York Times today (May 2) by Gina Kolata reviewed studies that affirmed the genetic basis of cancer. Genetic analysis of hundreds of tumors for endometrial cancer and leukemias found patterns of genetic aberrations that more precisely classify tumors. Knowing which genes are mutated will allow researchers to target therapy according to the gene fingerprint.

    A private company in the field Foundation Medicine already provides clinical laboratory services to allow physicians to tailor therapy to a tumor's subtype.

    A related news item in molecular diagnostics for cancer, Genomic Health (GHDX $31.95 ) announced that validation studies of their Oncotype DX Prostate Cancer Test will be presented on May 8 at the 2013 American Urological Association (AUA) Meeting in San Diego, with the test to be made available by the end of Q2 2013. Genomic Health announced financial results last night and Q1 revenues were up 8% to $63.1 compared to $58.5 with a net loss of $0.9M as operating expenses were up. U.S. invasive breast cancer studies were up 9%. Genomic Health was added to the Rayno Dx and Tools portfolio on Feb 26 at a Price of $28.50.

    Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

    Stocks: GHDX
Back To Rod Raynovich's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »

Latest Comments

Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.